Nearly half of camels in parts of Kenya have been infected by the virus that causes Middle East respiratory syndrome (MERS), according to a study published in PLOS ONE. The study calls for further research into the role camels might play in the transmission of this emerging disease to humans.
MERS was first identified in Saudi Arabia in 2012 and there is currently no vaccine or specific treatment available. To date, it has infected 1,595 people in more than 20 countries and caused 571 deaths. Although the majority of human cases of MERS have been attributed to human-to-human infections, camels are likely to be a major reservoir host for the virus and an animal source of MERS infection in humans.
A team of scientists from the University of Liverpool and institutions in the USA, Kenya and Europe, surveyed 335 dromedary (single humped) camels from nine herds in Laikipia County, Kenya and found that 47% tested positive for MERS antibodies, showing they had been exposed to the virus.
“Although Laikipia County camel density is low relative to more northern regions of Kenya, our study suggests the population is sufficient to maintain high rates of viral transmission and that camels may be constantly re-infected and serve as long term carriers of the virus. MERS in camels, it seems, is much like being infected by the common cold,” said professor Eric Fèvre, chair of Veterinary Infectious Diseases at the University’s Institute of Infection and Global Health. “The significance of this is not yet clear, because we don’t know if the virus is universally zoonotic. While the risk of these camels spreading MERS to humans cannot yet be discounted, it appears to be, for now, very low as there have been no human cases diagnosed in Kenya.”